Get ready for the LIVe 2022 !
Thank you for being here !
If you are enjoying our Digital LIVe 2021, you will certainly be interested in the upcoming LIVe 2022, which will take place in Nice, France on 13th and 14th June 2022 !
Chips and interconnections
 |
Clémentine Richter, Helmholtz-Institute for Pharmaceutical Research Saarland : The relevance of immune cells in alveolar inflammation modelling on a breathing lung-on-chip |
COVID-19
 |
Rémy Robinot, Institut Pasteur : SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance |
Exposure devices
 |
Tobias Krebs, Vitrocell Systems GmbH : A Family of Exposure Systems Suitable for Nebulized Solutions and Suspensions |
 |
Tobias Krebs, Vitrocell Systems GmbH : Dosimetry via Quartz Crystal Microbalances in Air-Liquid-Interface Cell Exposure Systems |
 |
Chang Guo, Public Health England : Characterisation of an air-liquid-interface aerosol-exposure system to facilitate hazard identification of nanoparticle exposure in human relevant culture models |
Infectious diseases
 |
Sandro Steiner, Philip Morris Products S.A. : In vitro testing of salt coating of fabrics as a potential antiviral agent in reusable face masks |
 on in vitro 3D human airway epithelium-thumb.png) |
Rosy Bonfante, Epithelix : Ciliopathic and inflammatory effect of Poly (I:C) on in vitro 3D human airway epithelium |
Inhalation toxicity testing
 |
Sonja Boland, University of Paris : Long-term effects of silver nanoparticles after repeated treatments of the bronchial epithelium using a newly developed 3D model of Calu-3 cells cultured at the air-liquid interface |
 |
Andreas Stucki, PETA Science Consortium International : Assessing Respiratory Toxicity in Two Human Cell-Based In Vitro Systems |
 |
Yvonne Staal, RIVM : Dose and effect of e-cigarette vape in an airway in vitro model |
 |
Jorid Sørli, The National Research Centre for the Working Environment : Lung surfactant inhibition as a predictor for lung toxicity |
 |
Arunima Sengupta, University of Bern : Toxicity profiling of compounds and nanoparticles in a breathing lung-on-chip model |
 |
Camila Branco, Epithelix : Primary human 3D airway-macrophage culture platform to assess toxicity of suspended vs aerosolized ZnO nanoparticles |
Modeling COPD/Asthma/IPF and CF
 for identification of new antiviral-anti-inflammatory drug repurposing opportunities to treat COVID-19-thumb.png) |
Hanan Osman-Ponchet, PKDERM Laboratories : Calu-3 cells as New Approach Methodologie (NAM) for identification of new antiviral/anti-inflammatory drug repurposing opportunities to treat COVID-19 |
 |
Nuria Roldan, AlveoliX AG : Modeling Pulmonary Fibrosis in a Microphysiological System - a tool for drug efficacy studies |
 |
Tom Wahlicht, InSCREENeX GmbH : Novel immortalised basal airway epithelial cells |
 |
Ali Doryab, Institute of Lung Biology and Disease (iLBD), Helmholtz Zentrum München : A Bioinspired in vitro Lung Model for Dynamic Culture under Air-Liquid Interface Conditions |
 |
Vasili Stylianidis, Maastricht University : Altered hyaluronic acid metabolism in response to IL-1β in the local lung microenvironment is associated with defective repair |
Think different
 |
Alberto Baeri, CNRS UMR 7275 : Elaboration of an in vitro test for the carcinogenesis evaluation of chemical and natural compounds used in the cosmetic industry |